Skip to Content
Merck

Argonaute2 mediates compensatory expansion of the pancreatic β cell.

Cell metabolism (2013-12-24)
Sudhir G Tattikota, Thomas Rathjen, Sarah J McAnulty, Hans-Hermann Wessels, Ildem Akerman, Martijn van de Bunt, Jean Hausser, Jonathan L S Esguerra, Anne Musahl, Amit K Pandey, Xintian You, Wei Chen, Pedro L Herrera, Paul R Johnson, Donal O'Carroll, Lena Eliasson, Mihaela Zavolan, Anna L Gloyn, Jorge Ferrer, Ruby Shalom-Feuerstein, Daniel Aberdam, Matthew N Poy
ABSTRACT

Pancreatic β cells adapt to compensate for increased metabolic demand during insulin resistance. Although the microRNA pathway has an essential role in β cell proliferation, the extent of its contribution is unclear. Here, we report that miR-184 is silenced in the pancreatic islets of insulin-resistant mouse models and type 2 diabetic human subjects. Reduction of miR-184 promotes the expression of its target Argonaute2 (Ago2), a component of the microRNA-induced silencing complex. Moreover, restoration of miR-184 in leptin-deficient ob/ob mice decreased Ago2 and prevented compensatory β cell expansion. Loss of Ago2 during insulin resistance blocked β cell growth and relieved the regulation of miR-375-targeted genes, including the growth suppressor Cadm1. Lastly, administration of a ketogenic diet to ob/ob mice rescued insulin sensitivity and miR-184 expression and restored Ago2 and β cell mass. This study identifies the targeting of Ago2 by miR-184 as an essential component of the compensatory response to regulate proliferation according to insulin sensitivity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-SLC25A22 antibody produced in rabbit, IgG fraction of antiserum
Roche
In Situ Cell Death Detection Kit, TMR red, sufficient for ≤50 tests